EICHOR
● Recruiting
A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006)
Condition: Diabetes Mellitus, Type 2 · Sponsor: Merck Sharp & Dohme LLC
About this study
The purpose of this study is to learn about the safety and if people tolerate a study medicine called MK-1403. The study will also measure what happens to MK-1403 in the body of a person with type 2 diabetes (T2D) over time (pharmacokinetic or PK study), and how it affects the amount of high-sensitivity C-reactive protein (hsCRP) in a person's blood.
This description comes directly from the study's public registry record.
Talk to the study team
Toll Free Number · 1-888-577-8839 · Trialsites@msd.com
Always discuss trial participation with your own doctor first.
Locations (5)
| Anaheim Clinical Trials ( Site 0006) | Anaheim, California, United States | Recruiting |
| ProSciento Inc. ( Site 0001) | Chula Vista, California, United States | Recruiting |
| Advanced Pharma CR, LLC ( Site 0003) | Miami, Florida, United States | Recruiting |
| QPS-MRA, LLC ( Site 0004) | South Miami, Florida, United States | Recruiting |
| Bio-Kinetic Clinical Applications, LLC dba QPS-MO ( Site 0005) | Springfield, Missouri, United States | Completed |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07242469